Contribution of MRE11, RAD50, and NBS1 Genotypes to Bladder Cancer Susceptibility

Cheng-Hsi Liao1,2, Wen-Shin Chang3,4, Hou-Yu Shih3,4

  • 1Taichung Armed Forces General Hospital, Taichung, Taiwan, R.O.C.

PubMed
Abstract

Insights

The NBS1 rs2735383 genotype is linked to increased bladder cancer risk, especially in older adults, smokers, and drinkers. This finding suggests NBS1 genotype as a potential biomarker for bladder cancer susceptibility.

Area of Science:

  • Genetics
  • Oncology
  • Molecular Biology

Background:

  • Genome instability accelerates cancer development, often due to DNA damage response defects.
  • The MRE11-RAD50-NBS1 (MRN) complex is vital for DNA damage sensing and repair.
  • Limited research exists on MRN genotypes and bladder cancer (BLCA) susceptibility.

Purpose of the Study:

  • To investigate the association between MRN gene polymorphisms and BLCA risk.
  • To identify specific MRN genotypes that may influence susceptibility to bladder cancer.

Main Methods:

  • Genotyping of 14 single nucleotide polymorphisms (SNPs) within the MRE11, RAD50, and NBS1 genes.
  • Analysis of 375 BLCA cases and 375 controls to evaluate SNP contributions to BLCA susceptibility.

Main Results:

  • The NBS1 rs2735383 polymorphism was significantly associated with increased BLCA risk (p=0.0053).
  • Both CG and CC genotypes of NBS1 rs2735383 conferred higher risks (OR=1.48 and 1.95, respectively).
  • Subgroup analyses revealed NBS1 rs2735383 is linked to higher risk in individuals over 55, smokers, alcohol drinkers, and those with muscle-invasive disease.

Conclusions:

  • The NBS1 rs2735383 genotype may serve as a genetic biomarker for BLCA susceptibility.
  • This biomarker is particularly relevant in high-risk subpopulations like elders, smokers, drinkers, and patients with muscle-invasive disease.